Fine Organic Industries (FINEORG) Q2 25/26 earnings summary

Executive summary

• Exports contributed 55% of total revenue in Q2FY26 and H1FY26, with stable overall demand and improved domestic performance in Q2.

• Standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025, were approved and reviewed, with an unmodified limited review report from statutory auditors.

• Incorporated a US subsidiary and acquired land in South Carolina for future expansion.

• The company operates in a single segment: manufacturing of specialty chemicals.

• Issued ₹65 crore in preference shares for equity infusion in a wholly owned subsidiary.

Financial highlights

• Standalone Q2FY26 revenue was ₹572 crore, down 4% year-over-year; PAT was ₹95 crore, down 16%.

• H1FY26 standalone revenue grew 2.5% to ₹1,131 crore; PAT declined 11% to ₹188 crore.

• Consolidated Q2FY26 revenue was ₹597 crore, flat year-over-year; PAT was ₹109 crore, down 7%.

• H1FY26 consolidated revenue rose 3.5% to ₹1,186 crore; PAT fell 2% to ₹226 crore.

• Exceptional income of ₹6.98 crore (INR 698.40 lakhs) was recognized in both standalone and consolidated results due to insurance settlement for business interruption.

Outlook and guidance

• Export markets remain steady; domestic demand is improving.

• The company continues to focus on specialty chemicals manufacturing, with no change in segment reporting.

• Strategic expansion in the US aims to enhance manufacturing capabilities and global reach.